OTCM
VREOF
Market cap345mUSD
Oct 08, Last price
9.21USD
1D
2.02%
1Q
-7.41%
IPO
2,097.64%
Name
Goodness Growth Holdings Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Goodness Growth Holdings, Inc. is a U.S.-based cannabis enterprise guided by medical professionals. The company cultivates cannabis within sustainable greenhouse environments and manufactures premium, pharmaceutical-grade cannabis extracts. Its products are distributed through its own Green Goods and Goodness Growth branded retail dispensaries, alongside sales via third-party dispensaries. As of March 11, 2022, the company managed a total of 18 dispensaries, including two in Maryland, eight in Minnesota, four in New Mexico, and four in New York. Furthermore, it provided wholesale cannabis goods to external businesses across Arizona, Maryland, Minnesota, and New York. Formerly known as Vireo Health International Inc., the company adopted the Goodness Growth Holdings, Inc. name in June 2021, and its primary operations are based in Minneapolis, Minnesota.
Related entities
Subsidiaries
VIREO HEALTH, INC.
Key people
Roi Carthy
Managing Partner
Daniel B. Carneiro Da Cunha
Partner
Shaun P. Nugent
Chief Financial Officer · since 2019
Christian Gonzales
Executive Vice President of Operations · since 2019
Amber Shimpa
Chief Administrative Officer · since 2019
Harris Rabin
Chief Marketing Officer · since 2019
Lucien Celli
Director · since 2014
Chelsea A. Grayson
Director · since 2019
Judd Norquist
Director · since 2019
Headquarters & legal address
1040 West Georgia Street
Suite 410
Vancouver, BC V6E 4H1
CA
Suite 410
Vancouver, BC V6E 4H1
CA
Previous name
Dynamic Oil & Gas Exploration Inc.
Previous name
DARIEN BUSINESS DEVELOPMENT CORP.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||